Paradigm Biocapital Advisors LP - 21 Aug 2025 SCHEDULE 13G Report for Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AGIO)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol
AGIO
Shares outstanding
58,230,327 shares
Disclosed Ownership
3,027,977 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
28 Aug 2025, 16:31:10 UTC
Date of event
21 Aug 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Paradigm Biocapital Advisors LP disclosed 5.2% ownership in Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AGIO) on 21 Aug 2025."

Quick Takeaways

  • Paradigm Biocapital Advisors LP filed SCHEDULE 13G for Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AGIO).
  • Disclosed ownership: 5.2%.
  • Date of event: 21 Aug 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 28 Aug 2025, 16:31.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5.2% 3,027,977 3,027,977 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5.2% 3,027,977 3,027,977 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5.2% 3,027,977 3,027,977 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.6% 2,669,945 2,669,945 0 David K. Kim / Authorized Signatory N/A

Sponsored